Muscular Dystrophy, Congenital, With Cataracts And Intellectual Disability; Mdccaid
MDCCAID is an autosomal recessive form of muscular dystrophy with onset of progressive muscle weakness in early childhood. Almost all patients also have early-onset cataracts, most have intellectual disability of varying severity, and some have seizures (summary by Wiessner et al., 2017 and Osborn et al., 2017).
Genes related to Muscular Dystrophy, Congenital, With Cataracts And Intellectual Disability; Mdccaid
Clinical FeaturesTop most frequent phenotypes and symptoms related to Muscular Dystrophy, Congenital, With Cataracts And Intellectual Disability; Mdccaid
- Intellectual disability
- Global developmental delay
- Short stature
- Generalized hypotonia
- Muscle weakness
And another 26 symptoms. If you need more information about this disease we can help you.
Incidence and onset information— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.
Researches and researchersCurrently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.
Muscular Dystrophy, Congenital, With Cataracts And Intellectual Disability; Mdccaid Recommended genes panels
|Panel Name, Specifity and genes Tested/covered
By Fulgent Genetics Fulgent Genetics (United States).
You can get up to -7 more panels with our dedicated toolLearn more
Sources and references
You can check the following sources for additional information.OMIM Rare Disease Search Engine
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like WAARDENBURG SYNDROME, TYPE 2A; WS2A THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A 2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY SPASTIC PARAPLEGIA 23; SPG23